BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su Z, Wang X, Zheng L, Lyu T, Figini M, Wang B, Procissi D, Shangguan J, Sun C, Pan L, Qin L, Zhang B, Velichko Y, Salem R, Yaghmai V, Larson AC, Zhang Z. MRI-guided interventional natural killer cell delivery for liver tumor treatment. Cancer Med 2018;7:1860-9. [PMID: 29601672 DOI: 10.1002/cam4.1459] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ruff SM, Shannon AH, Beane JD, Pawlik TM. Highlighting novel targets in immunotherapy for liver cancer. Expert Review of Gastroenterology & Hepatology 2022. [DOI: 10.1080/17474124.2022.2150841] [Reference Citation Analysis]
2 Ruff SM, Shannon AH, Pawlik TM. Advances in Targeted Immunotherapy for Hepatobiliary Cancers. IJMS 2022;23:13961. [DOI: 10.3390/ijms232213961] [Reference Citation Analysis]
3 Uthaman S, Cutshaw G, Ghazvini S, Bardhan R. Nanomaterials for Natural Killer Cell-Based Immunoimaging and Immunotherapies in Cancer. ACS Appl Mater Interfaces 2022. [PMID: 36006784 DOI: 10.1021/acsami.2c08619] [Reference Citation Analysis]
4 Shalaby N, Dubois VP, Ronald J. Molecular imaging of cellular immunotherapies in experimental and therapeutic settings. Cancer Immunol Immunother 2021. [PMID: 34657195 DOI: 10.1007/s00262-021-03073-5] [Reference Citation Analysis]
5 Eresen A, Yang J, Scotti A, Cai K, Yaghmai V, Zhang Z. Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma. Ann Transl Med 2021;9:1089. [PMID: 34423001 DOI: 10.21037/atm-21-539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zheng Y, Li Y, Feng J, Li J, Ji J, Wu L, Yu Q, Dai W, Wu J, Zhou Y, Guo C. Cellular based immunotherapy for primary liver cancer. J Exp Clin Cancer Res 2021;40:250. [PMID: 34372912 DOI: 10.1186/s13046-021-02030-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
7 Woller N, Engelskircher SA, Wirth T, Wedemeyer H. Prospects and Challenges for T Cell-Based Therapies of HCC. Cells 2021;10:1651. [PMID: 34209393 DOI: 10.3390/cells10071651] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
8 Sim T, Choi B, Kwon SW, Kim KS, Choi H, Ross A, Kim DH. Magneto-Activation and Magnetic Resonance Imaging of Natural Killer Cells Labeled with Magnetic Nanocomplexes for the Treatment of Solid Tumors. ACS Nano 2021. [PMID: 34165964 DOI: 10.1021/acsnano.1c01889] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
9 Kim KS, Kim DH, Kim DH. Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles. Pharmaceutics 2021;13:525. [PMID: 33918941 DOI: 10.3390/pharmaceutics13040525] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
10 Helfer BM, Ponomarev V, Patrick PS, Blower PJ, Feitel A, Fruhwirth GO, Jackman S, Pereira Mouriès L, Park MVDZ, Srinivas M, Stuckey DJ, Thu MS, van den Hoorn T, Herberts CA, Shingleton WD. Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective. Cytotherapy 2021;23:757-73. [PMID: 33832818 DOI: 10.1016/j.jcyt.2021.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sier VQ, de Vries MR, van der Vorst JR, Vahrmeijer AL, van Kooten C, Cruz LJ, de Geus-Oei LF, Ferreira V, Sier CFM, Alves F, Muthana M. Cell-Based Tracers as Trojan Horses for Image-Guided Surgery. Int J Mol Sci 2021;22:E755. [PMID: 33451116 DOI: 10.3390/ijms22020755] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Harmsen S, Medine EI, Moroz M, Nurili F, Lobo J, Dong Y, Turkekul M, Pillarsetty NVK, Ting R, Ponomarev V, Akin O, Aras O. A dual-modal PET/near infrared fluorescent nanotag for long-term immune cell tracking. Biomaterials 2021;269:120630. [PMID: 33395580 DOI: 10.1016/j.biomaterials.2020.120630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Park HS, Kim J, Cho MY, Cho YJ, Suh YD, Nam SH, Hong KS. Effectual Labeling of Natural Killer Cells with Upconverting Nanoparticles by Electroporation for In Vivo Tracking and Biodistribution Assessment. ACS Appl Mater Interfaces 2020;12:49362-70. [PMID: 33050704 DOI: 10.1021/acsami.0c12849] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Qin L, Wang S, Dominguez D, Long A, Chen S, Fan J, Ahn J, Skakuj K, Huang Z, Lee A, Mirkin C, Zhang B. Development of Spherical Nucleic Acids for Prostate Cancer Immunotherapy. Front Immunol 2020;11:1333. [PMID: 32733447 DOI: 10.3389/fimmu.2020.01333] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
15 Gangadaran P, Rajendran RL, Ahn BC. Application of In Vivo Imaging Techniques for Monitoring Natural Killer Cell Migration and Tumor Infiltration. Cancers (Basel). 2020;12. [PMID: 32455886 DOI: 10.3390/cancers12051318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Shi Y, Men X, Li X, Yang Z, Wen H. Research progress and clinical prospect of immunocytotherapy for the treatment of hepatocellular carcinoma. Int Immunopharmacol 2020;82:106351. [PMID: 32143005 DOI: 10.1016/j.intimp.2020.106351] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
17 Fang P, Xiang L, Chen W, Li S, Huang S, Li J, Zhuge L, Jin L, Feng W, Chen Y, Pan C. LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3. Innate Immun 2019;25:99-109. [PMID: 30774011 DOI: 10.1177/1753425919827632] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 25.5] [Reference Citation Analysis]
18 Sutphin PD, Lamus D, Kalva SP, Li J, Corbin IR. Interventional Radiologic Therapies for Hepatocellular Carcinoma: From Where We Began to Where We Are Going. In: Hoshida Y, editor. Hepatocellular Carcinoma. Cham: Springer International Publishing; 2019. pp. 169-94. [DOI: 10.1007/978-3-030-21540-8_9] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Varani M, Auletta S, Signore A, Galli F. State of the Art of Natural Killer Cell Imaging: A Systematic Review. Cancers (Basel) 2019;11:E967. [PMID: 31324064 DOI: 10.3390/cancers11070967] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]